UK Lateral Flow Assays Market Size & Outlook, 2023-2030
The lateral flow assays market in UK is expected to reach a projected revenue of US$ 521.5 million by 2030. A compound annual growth rate of 5% is expected of UK lateral flow assays market from 2024 to 2030.
Revenue, 2023 (US$M)
$370.2
Forecast, 2030 (US$M)
$521.5
CAGR, 2024 - 2030
5%
Report Coverage
UK
UK lateral flow assays market, 2018-2030 (US$M)
Related Markets
UK lateral flow assays market highlights
- The UK lateral flow assays market generated a revenue of USD 370.2 million in 2023 and is expected to reach USD 521.5 million by 2030.
- The UK market is expected to grow at a CAGR of 5% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Lateral flow assays market data book summary
| Market revenue in 2023 | USD 370.2 million |
| Market revenue in 2030 | USD 521.5 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Lateral Flow Readers |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
Other key industry trends
- In terms of revenue, UK accounted for 3.6% of the global lateral flow assays market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK lateral flow assays market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 521.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lateral Flow Assays Market Scope
Lateral flow assays market segmentation & scope
COVID-19
Mosquito Borne Disease Testing
Influenza Testing
HIV Testing
HPV Testing
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
Other STI Testing
Hepatitis
Tuberculosis
Other Infectious Diseases
Troponin I and T Testing
CK-MB Testing
BNP and NT-Probnp Testing
Myoglobin Testing
D-Dimer Testing
Other Cardiac Marker Tests
Pregnancy Testing
Fertility Testing
Cholesterol Testing/Lipid Profile
Drugs of Abuse Testing
Other Clinical Tests
Veterinary Diagnostics
Food Safety & Environment Testing
Drug Development & Quality Testing
Hospitals & Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical & Biotechnology Companies
Others
Lateral Flow Assays Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK lateral flow assays market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.77% in 2023. Horizon Databook has segmented the UK lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
- UK Lateral Flow Assays Product Outlook (Revenue, USD Million, 2018-2030)
- Kits & Reagents
- Lateral Flow Readers
- Benchtop Readers
- Digital Readers
- UK Lateral Flow Assays Application Outlook (Revenue, USD Million, 2018-2030)
- Clinical Testing
- Infectious Disease Testing
- COVID-19
- Mosquito Borne Disease Testing
- Influenza Testing
- Sexually Transmitted Infection Testing
- HIV Testing
- HPV Testing
- Chlamydia Testing
- Gonorrhea Testing
- Syphilis Testing
- Other STI Testing
- Hepatitis
- Tuberculosis
- Other Infectious Diseases
- Cardiac Marker Testing
- Troponin I and T Testing
- CK-MB Testing
- BNP and NT-Probnp Testing
- Myoglobin Testing
- D-Dimer Testing
- Other Cardiac Marker Tests
- Pregnancy & Fetility Testing
- Pregnancy Testing
- Fertility Testing
- Cholesterol Testing/Lipid Profile
- Drugs of Abuse Testing
- Other Clinical Tests
- Infectious Disease Testing
- Veterinary Diagnostics
- Food Safety & Environment Testing
- Drug Development & Quality Testing
- Clinical Testing
- UK Lateral Flow Assays Technique Outlook (Revenue, USD Million, 2018-2030)
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
- UK Lateral Flow Assays End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical & Biotechnology Companies
- Others
- UK Lateral Flow Assays Test Type Outlook (Revenue, USD Million, 2018-2030)
- Lateral Flow Immunoassay
- Nucleic Acid Lateral Flow Assay
Reasons to subscribe to UK lateral flow assays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK lateral flow assays market databook
-
Our clientele includes a mix of lateral flow assays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into UK lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK lateral flow assays market size, by product, 2018-2030 (US$M)
UK Lateral Flow Assays Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
